Privium Fund Management’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Privium Fund Management’s Portfolio ROIVW Stock Details ROIVW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-665,878	Closed	-$1.59M	–	135
2023 Q2	$1.59M	Buy	665,878 +148,788	+29%	+$293K	0.46%	39
2023 Q1	$755K	Buy	517,090 +210,307	+69%	+$391K	0.25%	44
2022 Q4	$577K	Buy	+306,783	New	+$336K	0.22%	47

Privium Fund Management's ROIVW Position: Q3 2023 in Review

Privium Fund Management sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q3 2023, closing a stake of 665,878 shares — an estimated $1.59M sold.

Privium Fund Management first reported a position in ROIVW in Q4 2022 and held it in 3 quarters. The position peaked at $1.59M in Q2 2023. 0 funds tracked by Wall St. Rank hold ROIVW as of Q3 2023.

Privium Fund Management reported no remaining Roivant Sciences Ltd. Warrant position as of Q3 2023 after selling out during the quarter.
Privium Fund Management sold 665,878 Roivant Sciences Ltd. Warrant shares in Q3 2023, an estimated $1.59M.
Privium Fund Management first reported a position in Roivant Sciences Ltd. Warrant in Q4 2022 and held it in 3 quarters.
Privium Fund Management's Roivant Sciences Ltd. Warrant position peaked at $1.59M in Q2 2023.
0 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q3 2023.

Based on Privium Fund Management's 13F filing for Q3 2023, filed 6 Nov 2023.